Faculty of Business and Economics, Technical University Dresden, 01069 Dresden, Germany.
Future Value Group AG, 70771 Leinfelden-Echterdingen, Germany.
Int J Environ Res Public Health. 2021 Feb 23;18(4):2169. doi: 10.3390/ijerph18042169.
Worldwide, politicians, scientists, and entrepreneurs are operating under high uncertainty and incomplete information regarding the adequacy of measures to deal with the COVID-19 pandemic. It seems indisputable that only widespread and global immunity can bring normalization to social life. In this respect, the development of a vaccine was a milestone in pandemic control. However, within the EU, especially in Germany, the vaccination plan is increasingly faltering, and criticism is growing louder. This paper considers the EU's political decision in general and the decisions of the German government to procure vaccine doses against the background of modern economics as a decision under uncertainty and critically analyzes the process.
在全球范围内，政治家、科学家和企业家在应对 COVID-19 大流行的措施是否充分方面面临着高度的不确定性和不完全的信息。只有广泛和全球性的免疫才能使社会生活恢复正常，这似乎是无可争议的。在这方面，疫苗的开发是控制大流行的一个里程碑。然而，在欧盟内部，特别是在德国，疫苗接种计划越来越步履维艰，批评声越来越大。本文考虑了欧盟的政治决策，特别是德国政府在现代经济学背景下为采购疫苗剂量所做的决策，作为一个不确定条件下的决策，并对此过程进行了批判性分析。
